John B. Landis - 03 Jan 2025 Form 4 Insider Report for EyePoint Pharmaceuticals, Inc. (EYPT)

Role: Director
Signature: /s/ Ron Honig, Attorney-in-Fact
Issuer symbol: EYPT
Transactions as of: 03 Jan 2025
Net transactions value: $0
Form type: 4
Filing time: 07 Jan 2025, 16:04:03 UTC
Previous filing: 09 Jan 2024
Next filing: 06 Jan 2026
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EYPT	Common Stock	Options Exercise	$0	+10,000	+88%	$0.000000	21,400	05 Jan 2025	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	EYPT	Stock Option (Right to Buy)	Award	$0	+40,000		$0.000000	40,000	03 Jan 2025	Common Stock	40,000	$8.26	Direct
transaction	EYPT	Restricted Stock Units	Options Exercise	$0	-10,000	-100%	$0.000000	0	05 Jan 2025	Common Stock	10,000	$0.000000	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Fully vested on the one-year anniversary of the grant date.